Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$16.1M
5 rounds on record
Latest round
$5.8M
Series B · Oct 2025 · 11 mo ago
Team
51-200
employees, estimated range
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 12, 2022 New executive Plastomics Inc. Names New CEO as Novel Trait Delivery Platform Progresses · markets.businessinsider.com Sep 13, 2021 Raised a round Venture round $7.1M · SEC Form D Apr 23, 2021 Raised a round Venture round $3.2M · SEC Form D Dec 4, 2017 Took on debt financing $2.4M · SEC Form D Dec 4, 2017 Took on debt financing $2.4M · SEC Form D 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Series B Oct 2025 $5.8M — marketwatch.com
Venture round Sep 2021 $7.1M — SEC Form D
Venture round Apr 2021 $3.2M — SEC Form D
Debt Financing Dec 2017 $2.4M — SEC Form D
Debt Financing Dec 2017 $2.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Plastomics Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Sharon BerberichExecutive Officer, DirectorSEC Form D
Jeffrey StaubExecutive Officer, DirectorSEC Form D
Elizabeth GallegosExecutive OfficerSEC Form D
Martha SchlicherExecutive Officer, DirectorSEC Form D
Gallegos ElizabethExecutive OfficerSEC Form D
Similar startupsby what they do, their industry and backers
Resurrect BioSeries A $8.1M · 7 mo ago • Founded 2023 • 11-50 employees
Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide…
Biographica Ltd201-500 employees
Biographica is a biotechnology company combining AI and rapid experimentation to design and develop better plant traits.
Foray Biosciences11-50 employees
The future of plant production starts at the origin of life. Foray uses plant cells and AI-powered plant biology to grow materials…
Variant BioVenture round $105M · 4 yr ago • Founded 2018 • 201-500 employees
Variant Bio is developing life-saving therapies by studying the genes of people with exceptional health-related traits.
Draupnir Bio is developing new innovative therapies for patients.
Trotana is developing novel oral anti-inflammatory medicines.

Overview

THE PLASTOMICS' ADVANTAGE. NATURAL EFFICIENCY Plastomics is developing a novel trait delivery technology that places beneficial traits in the chloroplast of plant cells, rather than the nucleus.

News

News Pulse 2.0 11 months ago
Plastomics: $5.8 Million Series B Closed For Advancing Corn Chloroplast Transformation Technology
Plastomics, a leader in agricultural biotechnology, has completed the initial close of its Series B round, securing $5.8 million to accelerate innovation in crop science through its proprietary chloroplast engineering platform. The round included investme
Read more
Report
Press release PRNewswire 11 months ago
Plastomics Announces Initial Close of Series B Financing to Advance Groundbreaking Corn Chloroplast Transformation Technology
/PRNewswire/ -- Plastomics, a cutting-edge leader in agricultural biotechnology, recently announced the successful initial close of its Series B funding round....
Read more
Report
Press release PRNewswire 5 years ago
Plastomics and Evogene
/PRNewswire/ -- Plastomics, Inc., an agricultural biotech company, developing a step change in trait delivery technology, and Evogene Ltd.
Read more
Report
Pro access
Upgrade to see all 16 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Sharon Berberich
Executive Officer, Director
Jeffrey Staub
Executive Officer, Director
Elizabeth Gallegos
Executive Officer
Martha Schlicher
Executive Officer, Director
Gallegos Elizabeth
Executive Officer
Dave Duncan
Director
Charles Bolten
Director
Brian Clevinger
Director
Steve Welker
Director
John Peryam
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Saint Louis United States
HQ
50-200 est. staff

Financials

Total raised
$20.9M
Latest round
Series B
Funding rounds
5
Funding rounds
Round Announced Amount
Series B 2025 $5.8M Details
Venture - Series Unknown 2021 $7.1M Details
Venture - Series Unknown 2021 $3.2M Details
Debt Financing 2017 $2.4M Details
Debt Financing 2017 $2.4M Details